Moreover, IL-6 induces severe immune and metabolic alterations, such as cachexia, which characterize advanced cancer and contribute to CRA pathogenesis, and which can be prevented with anti-IL-6 monoclonal antibodies [41]. This evidence concerns the gene IL6 and cancer.